This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Potent Neuromodulator With Therapeutic Potential

John W. Holaday, PhD; Edward W. Bernton, MD

Arch Intern Med. 1984;144(6):1138-1140.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The isolation of thyrotropin-releasing hormone (TRH, protirelin) in 1969^1,2 allowed an initial definition of specific biochemical mechanisms by which the brain regulates the release of pituitary hormones. The neuroendocrine role of TRH (initiating the pituitary release of thyrotropin) still remains as the best resolved physiologic function of this tripeptide molecule.³

See also p 1149.

The name "thyrotropin-releasing hormone," reflecting this hypophysiotropic action, is perhaps overly restrictive in light of further discoveries during the last 15 years. It has been demonstrated that TRH and its receptors are widely distributed within the CNS and in peripheral organs, and that the numerous pharmacologic effects of this substance include potent actions on autonomic, somatic, and behavioral systems.^3-5 These properties of TRH are independent of its pituitary-thyroid involvement and seem to indicate that TRH has more universal functions as a neuromodulator. The pharmacologic use of TRH may therefore prove to have great . . . [Full Text PDF of this Article]

Author Affiliations
Neuropharmacology Branch Department of Medical Neurosciences Division of Neuropsychiatry Walter Reed Army Institute of Research Washington, DC 20307

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?